Pharmaxis Ltd ADR (PXSLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2023 | 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,648 | -1,405 | -2,219 | -9,363 | -14,346 |
| Depreciation Amortization | 1,244 | 2,349 | 2,355 | 2,173 | 1,873 |
| Accounts receivable | 179 | -1,026 | 216 | -193 | 220 |
| Accounts payable and accrued liabilities | 724 | -453 | -389 | -293 | 48 |
| Other Working Capital | -39 | -4,265 | 2,972 | -1,053 | -3,838 |
| Other Operating Activity | 640 | -6,882 | -640 | -191 | 1,883 |
| Operating Cash Flow | $-4,899 | $-11,682 | $2,295 | $-8,920 | $-14,160 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -88 | -47 | -246 | -174 | -412 |
| Purchase Sale Intangibles | N/A | -175 | -235 | -212 | -290 |
| Other Investing Activity | 0 | -175 | -235 | -212 | -290 |
| Investing Cash Flow | $-88 | $-222 | $-481 | $-385 | $-702 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -1,726 | N/A | N/A | N/A |
| Common Stock Issued | 6,732 | 7,068 | 3,262 | N/A | 17,165 |
| Other Financing Activity | -2,034 | -530 | -2,127 | -1,680 | -2,267 |
| Financing Cash Flow | $4,698 | $4,812 | $1,136 | $-1,680 | $14,898 |
| Exchange Rate Effect | 486 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 6,016 | 13,576 | 11,032 | 20,900 | 22,223 |
| End Cash Position | 6,214 | 6,484 | 13,982 | 9,914 | 22,260 |
| Net Cash Flow | $197 | $-7,092 | $2,950 | $-10,986 | $37 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,899 | -11,682 | 2,295 | -8,920 | -14,160 |
| Capital Expenditure | -93 | -48 | -248 | -174 | -412 |
| Free Cash Flow | -4,992 | -11,730 | 2,047 | -9,094 | -14,572 |